Bridges already confused about policy costings

Source: New Zealand Government

Simon Bridges has added to confusion about the costings of National’s tax policy today, and needs to clear up how much New Zealanders would get and how the plan would be paid for, Finance Minister Grant Robertson says.

“National have published two different numbers inside two days for how much someone on the average wage would get under the policy. On Wednesday, it was $430 a year. By Thursday, that had fallen to $400, according to Simon Bridges’ Magic op-ed – a 7% difference.

“Yesterday, someone on the average wage was going to get over $8 a week. Now, it’s less than $7.70, according to National’s new numbers.

“Simon Bridges’ policy is deflating before our very eyes.

“National also appear confused about how much the policy will cost. When the Magic op-ed was initially published, Bridges the plan would cost both $650 million and $750 million – a 15% difference within three paragraphs.

“Ever since Bill English left, National haven’t been able to cost their policies. When Simon Bridges announced his classroom size policy last year, he didn’t have any idea of how much it would cost. Six months later, National still haven’t shown us the money.

“There must be a spreadsheet somewhere.

“Alongside promising dozens of new roads while cutting the funding source to pay for them, and wild promises on debt targets and social spending, these confused costings will leave New Zealanders questioning National’s numbers.

“There are some simple questions for Simon Bridges to answer: How are you going to pay for this, and what services will be cut to do so? Until New Zealanders receive answers, these are just reckless and empty promises,” Grant Robertson said.

MIL OSI

Cancer Care at a Crossroads Conference

Source: New Zealand Government

[CHECK AGAINST DELIVERY]

Introduction

Thank you, Professor Hayne (Vice Chancellor, University of Otago), for your kind introduction.

And thank you, Blair and Melissa (Vining) for bravely sharing your cancer journey with us today. 
Your speech from a personal perspective is an ideal start to this conference because people must be at the centre of cancer care – and across the whole health and disability sector. 

So thank you again, Blair, for reminding us about who matters most.

It’s my privilege today to formally open this Cancer Care at a Crossroads conference. 

There’s a huge amount of wisdom and experience about cancer in this audience today. 

You’re an influential and diverse group of people and include doctors, nurses, allied health workers, pharmacists, consumers, researchers, community leaders, funders and planners, and others involved in cancer prevention and care. 

I understand this is the biggest cancer conference in this country in 15 years. 

With all 400 seats booked out here at Te Papa’s biggest room, this is a big deal.
Some of you I’ve had the pleasure to meet previously and others I look forward to sitting down with in future.

I’d like to acknowledge and thank you all for your dedication and commitment to cancer prevention and care. 

You’re helping to ensure better outcomes for New Zealanders, and you can rightly feel proud of your important contribution.
I’d like to thank the conference’s co-hosts, the University of Otago and the Cancer Society of New Zealand, supported by the New Zealand Society of Oncology and the Ministry of Health, for putting together an excellent programme.

It’s both inspirational and essential for the sector to collaborate together for the good of all New Zealanders.

I’d like to acknowledge the Cancer Society’s Mike Kernaghan and Dr Chris Jackson and University of Otago’s Professor Diana Sarfati for your gentle friendship; accompanied by vigorous and persistent advocacy and evidence-based lobbying.

A warm welcome to our international guests – Professor Richard Sullivan, Dr Rami Rahal, Professor David Currow and Professor Fatima Cardoso, and to all our national and local guests.

I’d also like to acknowledge and thank the speakers from last night’s event at Parliament – including Professor Sir David Skegg, singer/songwriter Pip Brown – who we know as LadyHawke – and former Black Caps coach Mike Hesson.

Challenges of cancer control

I’ve been asked to speak to you this morning about the challenges of cancer control in Aotearoa New Zealand.

This is an important issue for me. 

There will be few people, if any, in New Zealand who haven’t had their lives touched by cancer, whether they’ve had cancer themselves or had a loved one diagnosed with cancer. 

Overall, New Zealand ranks middle of the pack among 15 comparable countries in terms of the overall impact of cancer. Being a developed country, this means we’re ahead of most of the world. But I wouldn’t think there is a person in this room who doesn’t think we need to do better.

Our overall success has much to do with your hard work and is something you can all rightly feel proud of.
However, we know cancer’s burden is not equally shared by all New Zealanders. 
Maōri are nearly twice as likely to die of cancer compared to non-Maōri and are about 20 per cent more likely to get cancer. 
Maōri are often diagnosed late, which means cancer is more progressed, affecting treatment options and worsening outcomes. 

Cancer outcomes are also worse for people living in poverty, those with chronic health conditions and mental health problems, and those living in rural areas. 
Maōri are over-represented in these categories, as are Pacific peoples.

Responding to the challenges 

I’ve been concerned about the growing inequities that have been apparent in New Zealand for some time and that’s one of the main reasons I got into politics. 

Achieving equity is a strong focus for the Coalition Government, so I’d like to talk about some of the work we’ve been doing over the past 15 months in the health and disability sector, to improve sustainability and access to health care.

Better access to primary health care is at the heart of an effective equitable public health system and putting a greater focus on primary care is one of my priorities.

Cost stopped 585,000 adults from visiting their general practice during 2017/18 – that’s about 15 per cent of our country’s entire adult population – according to the latest annual New Zealand Health Survey. 

For Maōri, it was worse. One in five Maōri adults say they couldn’t go to a GP because of cost, according to the same survey.
Last December 1, the Government extended the Very Low Cost Access scheme to all community service card holders, which lowered the cost of primary care visits by an average of $20 to $30 for an extra 540,000 New Zealanders. 

At the same time, we expanded the zero fees for under 13s for primary care visits to include under 14s, which benefitted a further 56,000 young people.

We believe making primary care visits more affordable to those who need them most will improve access and health outcomes.

Not only does will it make doctors’ visits more affordable, it may mean patients make those appointments when they may otherwise choose not to because of cost.

Better access to timely primary health care assists in maintaining people’s wellness and good health, and can keep them out of hospital.
I have no doubt that for some it will result in the earlier detection and treatment of diseases including cancer.

Improving the state of our hospitals and health facilities is another of my priorities. 

Some of our buildings are earthquake prone, others are no longer fit-for-purpose, and we also need to address growing capacity challenges and demand for services.

In our first budget, we put aside $750 million for capital expenditure and to date, we’ve allocated more than $700 million to funding key projects.

We want facilities that you’re proud to work in and that help you to achieve top health outcomes for people.

Mental health is another of my priorities. 

People with mental health problems have worse outcomes in cancer, so this work is relevant to you all. 

The Government initiated a ministerial inquiry into mental health and addictions within our first 100 days and we received the inquiry panel’s report late last year. 

It’s a substantial and thorough piece of work and it’s important we take time to fully digest and consider its 40 recommendations. I expect to formally respond by the end of March, which gives Cabinet time to take important decisions in time for our Wellbeing Budget in May. 

We can all be justifiably proud of our public health system’s performance, including in cancer control, but we can’t get complacent, or ignore the need to keep doing better. 

I set up the Health and Disability System Review in May last year to future-proof our health and disability services.

This major review, being led by Heather Simpson, is identifying opportunities to improve the performance, structure, and sustainability of our health system with a goal of achieving equity of outcomes, and contributing to wellness for all, particularly Māori and Pacific peoples.

This review is a once-in-a-generation opportunity to improve equity and outcomes for New Zealanders, and will chart a course for a fairer, more sustainable health and disability system that is well-placed to respond to the future needs of all New Zealanders. 

It’s an important opportunity for you all and I encourage you to take the time to engage with this review and to share your solutions for facing the challenges in cancer control.

The panel has gathered initial feedback from a wide range of health and disability sector participants, and has recently opened its online process so all interested parties can contribute their views to how our health and disability system can be improved. 

The review panel’s interim report is due to me by the end of August, and I’ll get their final report by the end of March next year.

The Ministry of Health has a comprehensive programme of work underway to develop people-centred standards of care to support quality improvement across cancer care and treatment. 

The standards will be measured by quality performance indicators and the first one is for bowel cancer, which will be presented later today by Professor Ian Bissett.

We’ve started developing clinical quality indicators with the sector for lung, prostate, melanoma, gynaecological and neuroendocrine tumours, and ultimately plan to have quality performance indicators for all tumour streams.

You’ll also hear from Dr Shaun Costello tomorrow about radiation oncology and a new initiative that collects and presents radiation data, which will help us to understand variations of care around New Zealand.

I acknowledge that it can be uncomfortable and confronting for us all to compare how DHBs perform for cancer, but it’s vital to know where disparities exist around New Zealand so that we can address them and improve our national consistency of care. 

DHBs are already using this radiation oncology information to guide their practice.

Soon after I became Minister of Health, I discovered problems had occurred with the bowel screening pilot programme, which ran from 2011 to the end of 2017, where some people didn’t receive invitations to be screened. 

There was also a series of delays which had concerned me, governance concerns and reports of extraordinarily optimistic roll-out timetables given existing IT constraints.

I initiated an independent review of the National Bowel Screening Programme because of its serious health implications.

I wanted to be sure that everything possible was done to avoid those problems recurring and to prevent further issues – in so far as that is possible in a new programme.

That review looked at a broad range of factors, including information technology, District Health Board capacity, operational management and clinical factors.

The report of the review, led by Professor Gregor Coster, endorsed the ongoing roll-out of the programme around New Zealand, and made a number of wide-ranging recommendations to support its continued improvement.

Those recommendations are helping to ensure the programme is safe and effective. 

We know screening programmes save lives and this review confirmed that despite some issues with the pilot programme, overall it performed well, which should boost public confidence in it.

Since becoming Minister of Health, I’ve taken the opportunity to hear from many of you about how we can improve our country’s cancer control. 

I also asked health officials to engage widely with the sector to develop some options to improve national consistency, equity and health outcomes for cancer control. 

I’ve listened to your feedback to me directly and to health officials. There is widespread agreement that we need stronger leadership of our cancer control.

At the same time, the Ministry of Health has become better placed to provide this stronger stewardship and leadership of cancer prevention and control and delivery of better outcomes at the national level.

I’ve asked the Director-General of Health, Dr Ashley Bloomfield, to take a driving role in this.

The central strand of this work from this point will be the development of a new cancer action plan, with the bold goal of achieving equity of outcomes as a priority.

When my former colleague and former Minister of Health, Dame Annette King, launched New Zealand’s Cancer Control Strategy in 2003, she said the strategy encouraged government and non-government providers to work closely together to achieve long-term change. 

The importance of that collaboration remains today.

I acknowledge there are different opinions on priorities, how changes should be made and who should lead them, but it’s clear we all need to work together on this cancer action plan.

The Director-General will speak to you later this morning about how the Ministry intends to progress this new cancer action plan and how it will work with the sector to strengthen leadership of cancer control.

We’re going to start building the action plan alongside you all through this conference and at the workshops run by the Ministry this Saturday. 
I’m pleased to hear that many of you have eagerly signed up for these workshops – thank you for your enthusiasm to engage.

The Ministry has intentionally used this opportunity so the expertise in this room can be harnessed to debate and discuss as a collective, and jointly determine the best way forward.
 
This is an important early step and I know there will be wider consultation as we work towards changing our whole health system to improve cancer care and outcomes.

Conclusion

This conference is a chance for us all to take a quantum leap in our collective thinking about how to solve our cancer problem together so that we lift New Zealand’s performance on cancer outcomes, particularly for Māori and other New Zealanders who experience the worst outcomes.

My hope is that everyone will share their knowledge and solutions at this important conference to help us better tackle cancer so that all New Zealanders can access appropriate care that they need and deserve, regardless of who they are or where they live.

This is our crossroads. This is our challenge. 

The opportunity in front of us is to design a road map, an action plan, for meaningful change. 

Let’s look to the future and what we want to see there: high-quality, equitable, sustainable, nationally-consistent care for all New Zealanders. 

I’m confident this is achievable and that we will succeed if we work together in partnership.

Thank you. 

MIL OSI

Health Quality & Safety Commission e-digest – Issue 94 online now

Source: Health Quality and Safety Commission

Ngā ihirangi | In this issue

Whakapai i te kounga me te haumaru | Quality and safety improvement

  • Dave’s story
  • Orders for Kia kōrero | Let’s talk advance care campaign resources

Whakaheke mōrearea | Reducing harm

  • New dosing guidelines for the treatment of paracetamol overdose and toxicity
  • 5 questions to ask about your medications – consumer safety poster available
  • More draft Frailty Care Guides available for testing
  • Blog: Māori health advancement – how can we do it?
  • Mental health and addiction tools and resources
  • Dispensing errors: Learning from the national primary care patient experience survey
  • Presentations and videos from Patient deterioration New Zealand: current state and future developments

Pūrongo me te whakamārama | Reporting and commentary

  • Maternal morbidity review toolkit for maternity services | Te kete arotake mate whakawhānau mō ngā ratonga whakawhānau
  • Evaluation of the early implementation of the national maternity early warning system
  • Guidelines for reporting on and talking about suicide in Aotearoa
  • New portal for quality and safety marker data
  • Survey finds nearly 70 percent of clinicians concerned about unnecessary medical interventions
  • Medical Council statement supports Choosing Wisely

Ngā hui huhua | Events

  • Upcoming events calendar
  • Serious illness conversation guide training
  • Continuing the conversation: A Choosing Wisely forum

Last updated 31/01/2019

MIL OSI

Beetle application could boost arsenal against weed moth plant

Source: Environmental Protection Authority

31 January 2019

We are considering an application to introduce a root-feeding beetle to control the weed moth plant, a noxious weed which smothers the growth of native plants in communities in the North Island.

The applicant is the Waikato Regional Council, acting on behalf of a consortium of regional councils and the Department of Conservation, known as the National Biocontrol Collective.

In documents filed by the applicant the Waikato Regional Council has spent more than 1400 hours of biosecurity staff time over the past six years helping to control 700 sites in Waikato where the weed has established itself. They describe weed moth plant (Araujia hortorum) as a significant threat to conservation values and urban environments.

Dr Clark Ehlers, Senior Advisor New Organisms says: “Moth weed plant is well established in Auckland and Northland and is known to spread across plants as well as backyard fences, walls and power poles, where is becomes the dominant species and replaces native plants.

“The latex sap from broken stems can cause skin burns and irritations and is toxic to dogs, poultry and cattle.”

“If the moth plant beetle (Freudeita cf cupripennis) is approved by the EPA, it would pave the way for the beetle to work alongside a rust fungus approved in 2015, Puccinia araujiae, to help control moth weed across New Zealand,” says Dr Ehlers.

Members of the public have until Friday 15 March 2019 to make a submission on the application.

Make a submission

MIL OSI

Passport fees to increase from March 1

Source: New Zealand Government

The fees for New Zealand passports will increase slightly in March, Internal Affairs Minister Tracey Martin announced today.

“The new fees will ensure that New Zealanders and their families continue to have a high quality passport and cover a funding gap associated with the move from five to 10 year passports,” says Ms Martin.

Under the new fee structure, the adult passport fee will increase from $180 to $191 while the child fee will increase from $105 to $111. The passport price is similar to that of the United Kingdom, the United States, and Canada.

The increase follows the first review of passport and travel document fees since the change of the adult passport validity period from five to ten years in 2015.

“The government has kept the fee increase to a minimum, but needed to cover a significant deficit in the memorandum account that funds the production of passports,” the Minister said.

“Without a change to passport fees, the cost of producing passports would not have been met and the Passports Memorandum Account was projected to be in deficit by more than $110 million in 10 years.”

The Minister said that the new prices that have been set will be in place for at least three years and cover planned improvements to ensure the security and ease of use of New Zealand passports.

“Quality passports make it easy for New Zealanders to travel internationally and our passport service is recognised for its innovation and good customer service. New Zealand passports provide access to visa-free travel to over 170 countries and use of the automated border control SmartGate service. We are also one of the few countries that offer fully online passport application services.” 

The Department of Internal Affairs reviews passport fees every three years. The next review is scheduled in 2021.

For more information on the passport fees structure go to https://www.passports.govt.nz/passport-costs/

ENDS

Contact: Richard Ninness 021 892 536

 

MIL OSI

UPDATE: Search for missing fishermen, Slope Point

Source: New Zealand Police

A coastal search for the two fishermen who went missing off rocks at Slope Point, near Bluff, on Sunday afternoon continues.

Police are now in a position to name the two men. They are 23-year-old Shaun Orchard and 28-year-old Hendrix Kamo, both of Southland.  The families of the two men are being supported by Police and Victim Support.

LandSAR are continuing to search daily in the wider Slope Point area, however all search activities are dependent on weather conditions at the time.

Police would like to acknowledge and thank the volunteers and staff who have been involved in the search to date for their commitment and dedication to finding these two men.

ENDS

Issued by Police Media Centre 

MIL OSI

Grant Robertson misses the point on bracket creep

Source: Taxpayers Union

31 JANUARY 2019FOR IMMEDIATE RELEASE
Grant Robertson’s response to Simon Bridges’ tax bracket indexation announcement indicates that he misses the point of the policy, says the New Zealand Taxpayers Union. Taxpayers’ Union Economist Joe Ascroft says, “It’s contradictory for the Finance Minister to argue both that indexation of tax brackets is too expensive, and that it’s a ‘small change’ tax cut.” “Tax bracket indexation is not a tax cut, and nor is it meant to be. Mr Robertson misses the point of the policy, which is that real tax rates are kept steady, meaning that any politician who wants to collect more revenue will have to openly legislate for a tax hike, and explain this decision to the public.” “Indexation would improve transparency by ending ongoing stealth tax hikes, and it would help voters hold politicians accountable for their revenue-grabbing.”

MIL OSI

New body armour to help keep Police safe

Source: New Zealand Police

Police Commissioner Mike Bush has today announced that new, enhanced body armour will be delivered to all Police officers in New Zealand over the next three years.
 
Police has signed a contract with Cooneen Protection for the manufacture and supply of the new body armour system, and with Tactical Solutions – Cooneen Protection’s New Zealand agents – to provide ongoing logistical support, including measuring and fitting.
 
“As Police, our vision is for New Zealand to be the safest country, and that starts with our staff. To keep communities safe, first Police must keep themselves safe,” Mr Bush says.
 
“So today I’m proud to announce we are investing in a new body armour system that will help keep Police safe.
 
“With more than a million interactions with the public every year, the vast majority of New Zealanders engage with us appropriately. However, it’s unfortunately the nature of Police work that some people want to harm us.
 
“Existing body armour remains safe and fit for purpose and I am confident that it will continue to keep Police safe while we roll out new body armour over the next three years.
 
“However, with advances in technology over the past 10 years, we have an opportunity to enhance Police body armour with a new, innovative body armour system that feels lighter and more comfortable, is more adjustable and customisable, while retaining all of the safety benefits of current body armour.”
 
The new armour is more adjustable and it better integrates the ballistic armour into the stab resistant armour and provides individually-issued tactical pouches. This gives Police staff options about where they carry their tactical equipment such as radio, OC spray, baton and handcuffs.
 
Police officers will also have direct access to their tactical equipment while wearing newly-designed high-visibility jackets.
 
“Police are often required to wear body armour for long shifts, in all weather, while remaining active. That’s why it’s so important the new body armour is more comfortable and easier to wear for long periods of time.”
 
Measuring and fitting of body armour is a key part of the process to ensure the armour is comfortable and safe. Police is partnering with Tactical Solutions, who will provide specialist measure and fit services across New Zealand, so Police have the right armour for their body size and shape.
 
The new body armour will be delivered to all Police officers over the next three years, between January 2019 and mid-2022.
 
“We’re investing in 1800 extra Police in the coming years. Today’s announcement ensures we are continuing to equip our staff with the tools they need to do their jobs safely in our communities every day.”
 
ENDS
 
Notes to editor
 
Police is investing $20.7m over four years to replace the existing body armour with the new body armour system. This includes making the body armour, measuring and fitting each officer correctly for a custom fit, and rolling out the new body armour across the country.
 
The body armour replacement process began in 2014 with a substantial review of current body armour. The review found that the current level of protection is sufficient to meet risks in an operational environment. However, opportunities were identified for enhancement, especially for carriage of equipment, comfort, and integration of ballistic armour plates. Police sought independent advice from Police operational staff and established a user group of frontline staff – including male and female officers, dog handler, highway patrol, and CIB. Feedback from this group was instrumental in selecting the new body armour system.
 
All Police officers will receive the new body armour. SRBA is worn by staff in response roles, when dealing with the public, and as the tactical situation calls for it.
Both current and new armour meet international safety standards for both stab and ballistic resistance. Every year a sample of our SRBA is tested by an independent laboratory in the UK to ensure it meets the required standard.
 
Examples of body armour preventing harm
 
Quotes taken from Police officers following incidents involving the existing Stab Resistant Body Armour (SRBA).
 
Anonymous Officer 1: “Upon entry [Subject] hit me with the crow bar to my chest area which I did not sustain an injury from as it hit my SRBA.”
 
Anonymous Officer 2: “My perceived cumulative assessment of his behaviour was that he intended to cause death or grievous bodily harm. This was based on the fact he had two substantially large knives in his possession, he ran at me with them and attempted to stab me with them. One knife which was 30cm in length was pushed into my chest but was stopped by my SRBA and the other was held above his head but before he could use it [Officer] had taken him to the ground.”
 
Anonymous Officer 3: “…he lashed out with his fists and struck me in the chest area…The offender continued to strike out at me with his fists and legs, due to this and his large size I was unable to turn him over and felt in danger of injury. The offender punched me in the chest several more times…Only my SRBA protected me from injury from the offender’s punches and kicks during this arrest.”
 

MIL OSI

January 2019 tender notification

Source: Pharmac

31 January 2019

PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2017/18 Invitation to Tender, dated 2 November 2017.

Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.

Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes

Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.

Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link)  and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.

2017/18 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2021

Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule

1. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current
pack price
New
pack price
Sole supply brand (Supplier) Date of listing Date of reference pricing of other listed brands Sole Subsidised Supply date Brand (Supplier) affected by reference pricing and delisting
Zoledronic acid1 Inj 4 mg per 5 ml, vial,
1 inj pack
$84.50 $35.03 Zoledronic Acid Mylan
(Mylan)
1 March 2019 1 May 2019 1 August 2019 Zometa (Novartis)
1 Access is unchanged

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule

2. Tenders awarded to pharmaceuticals where at least one other brand is listed.

The decisions were as follows:

Chemical name Presentation;
Pack size and type
Current pack price New pack price Hospital supply brand (Supplier) DV Limit Listing date Hospital Supply Status date Brand (Supplier) affected by delisting
Zoledronic acid2 Inj 4 mg per 5 ml, vial
1 inj pack
$84.50 $35.03 Zoledronic Acid Mylan
(Mylan)
1% 1 March 2019 1 May 2019 Zometa (Novartis)
2 Access is unchanged

Tender declines – Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status

PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in:

  • the 2017/18 Invitation to Tender, dated 2 November 2017.

2017/18 Invitation to Tender

Chemical name Line item
Zoledronic acid (access as at 2 Nov 2017)3 Inj 4 mg per 5 ml, vial
3 Access refers to zoledronic acid access as of 2 November 2017

For products included in the 2016/17 and 2017/18 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.

If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.

Last updated: 31 January 2019

MIL OSI

What is the Wellbeing Budget?

Source: New Zealand Labour Party

Last week, the Prime Minister attended the World Economic Forum at Davos. 

She used the opportunity to represent New Zealand on the world stage – and to promote our upcoming Wellbeing Budget 2019.

With this Budget, we’re doing things differently. 

We don’t think you can measure the success of a country through dollars and cents alone.

So – we’re widening our focus. 

Alongside GDP, we will measure ourselves against five key priorities that will make real improvements to the lives of New Zealanders. We’ve used evidence to identify the five areas we can make the greatest difference.

Boosting innovation

Supporting a thriving nation in the digital age through innovation, social and economic opportunities.

Creating opportunities

Assisting productive businesses, regions, iwi and others to transition to a sustainable and low-emissions economy.

Backing Māori & Pasifika

Lifting Māori and Pacific incomes, skills and opportunities.

Supporting Mental Health

Supporting mental wellbeing for all New Zealanders, with a special focus on under 24 year-olds.

Improving Child Wellbeing

Reducing child poverty and improving child wellbeing, including addressing family violence.

Post by NZLabourParty.

We will continue to measure economic growth, balance our books responsibly, run a healthy surplus, and spend well within our means. 

However, this widened focus will require any Minister that wants to spend money to prove this investment will improve inter-generational wellbeing.

It’s an approach led by kindness and compassion – and it’s simply the right thing to do.

MIL OSI